Cacospongionolide B

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 412219

CAS#: 172854-76-1

Description: Cacospongionolide B is isolated from the sponge Fasciospongia cavernosa. The marine sponge natural product cacospongionolide B (1) is one of a class of compounds bearing a g-hydroxybutenolide which are known to inhibit multiple forms of secratory phospholipase A2,1 enzymes believed to initiate a cascade of biological events leading to inflammation.

Chemical Structure

img
Cacospongionolide B
CAS# 172854-76-1
Instruction

Theoretical Analysis

MedKoo Cat#: 412219
Name: Cacospongionolide B
CAS#: 172854-76-1
Chemical Formula: C25H36O4
Exact Mass: 400.26
Molecular Weight: 400.560
Elemental Analysis: C, 74.96; H, 9.06; O, 15.98

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Cacospongionolide B

IUPAC/Chemical Name: 2(5H)-Furanone, 4-((2R)-5-(2-((1S,2S,4aR,8aR)-decahydro-1,2,4a-trimethyl-5-methylene-1-naphthalenyl)ethyl)-3,6-dihydro-2H-pyran-2-yl)-5-hydroxy-,(5R)-

InChi Key: CVAZWHZRZNYCOV-DRCQBYJMSA-N

InChi Code: InChI=1S/C25H36O4/c1-16-6-5-7-21-24(16,3)12-10-17(2)25(21,4)13-11-18-8-9-20(28-15-18)19-14-22(26)29-23(19)27/h8,14,17,20-21,23,27H,1,5-7,9-13,15H2,2-4H3/t17-,20+,21-,23+,24-,25-/m0/s1

SMILES Code: O=C1O[C@@H](O)C([C@H]2CC=C(CC[C@@]3(C)[C@@H](C)CC[C@@]4(C)C(CCC[C@]34[H])=C)CO2)=C1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 400.56 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: De Stefano D, Tommonaro G, Malik SA, Iodice C, De Rosa S, Maiuri MC, Carnuccio R. Cacospongionolide and scalaradial, two marine sesterterpenoids as potent apoptosis-inducing factors in human carcinoma cell lines. PLoS One. 2012;7(4):e33031. doi: 10.1371/journal.pone.0033031. Epub 2012 Apr 3. PMID: 22509253; PMCID: PMC3317917.

2: Murelli RP, Cheung AK, Snapper ML. Conformationally restricted (+)-cacospongionolide B analogues. Influence on secretory phospholipase A2 inhibition. J Org Chem. 2007 Mar 2;72(5):1545-52. doi: 10.1021/jo061407a. PMID: 17315974.

3: Alcaraz MJ, Payá M. Marine sponge metabolites for the control of inflammatory diseases. Curr Opin Investig Drugs. 2006 Nov;7(11):974-9. PMID: 17117584.

4: Cheung AK, Murelli R, Snapper ML. Total syntheses of (+)- and (-)-cacospongionolide B, cacospongionolide e, and related analogues. Preliminary study of structural features required for phospholipase a2 inhibition. J Org Chem. 2004 Aug 20;69(17):5712-9. doi: 10.1021/jo049285e. PMID: 15307744.

5: Posadas I, De Rosa S, Terencio MC, Payá M, Alcaraz MJ. Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor- alpha by inhibiting nuclear factor-kappa B activation. Br J Pharmacol. 2003 Apr;138(8):1571-9. doi: 10.1038/sj.bjp.0705189. PMID: 12721113; PMCID: PMC1573800.

6: Cheung AK, Snapper ML. Total syntheses of (+)- and (-)-cacospongionolide B: new insight into structural requirements for phospholipase A(2) inhibition. J Am Chem Soc. 2002 Oct 2;124(39):11584-5. doi: 10.1021/ja026899x. PMID: 12296709.

7: De Rosa S, Crispino A, De Giulio A, Iodice C, Amodeo P, Tancredi T. A new cacospongionolide derivative from the sponge Fasciospongia cavernosa. J Nat Prod. 1999 Sep;62(9):1316-8. doi: 10.1021/np990125l. PMID: 10514323.

8: García Pastor P, De Rosa S, De Giulio A, Payá M, Alcaraz MJ. Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2. Br J Pharmacol. 1999 Jan;126(1):301-11. doi: 10.1038/sj.bjp.0702302. PMID: 10051149; PMCID: PMC1565805.

9: De Rosa M, Giordano S, Scettri A, Sodano G, Soriente A, Pastor PG, Alcaraz MJ, Payá M. Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues. J Med Chem. 1998 Aug 13;41(17):3232-8. doi: 10.1021/jm980027h. PMID: 9703468.

10: De Rosa S, Crispino A, De Giulio A, Iodice C, Pronzato R, Zavodnik N. Cacospongionolide B, a new sesterterpene from the sponge Fasciospongia cavernosa. J Nat Prod. 1995 Nov;58(11):1776-80. doi: 10.1021/np50125a024. PMID: 8594155.